|

Liquid Biopsy in Mature B-cell Tumors

RECRUITINGSponsored by Oncology Institute of Southern Switzerland
Actively Recruiting
SponsorOncology Institute of Southern Switzerland
Started2017-09-01
Est. completion2027-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03280394

Summary

The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or female adults 18 years or older
* Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
* Willing and able to comply with scheduled study procedures
* Evidence of a signed informed consent

Conditions2

CancerMature B-Cell Neoplasm

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.